Menu
GeneBe

OTULIN

OTU deubiquitinase with linear linkage specificity, the group of OTU domain containing

Basic information

Region (hg38): 5:14664663-14699850

Previous symbols: [ "FAM105B" ]

Links

ENSG00000154124NCBI:90268OMIM:615712HGNC:25118Uniprot:Q96BN8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • infantile-onset periodic fever-panniculitis-dermatosis syndrome (Definitive), mode of inheritance: AR
  • infantile-onset periodic fever-panniculitis-dermatosis syndrome (Strong), mode of inheritance: AR
  • infantile-onset periodic fever-panniculitis-dermatosis syndrome (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection; Autoinflammation, panniculitis, and dermatosis syndromeAD/ARAllergy/Immunology/InfectiousImmunodeficiency 107, susceptibility to invasive staphylococcus aureus infection can involved increased risk of certain types of infections, and awareness may allow prompt management of infections; Autoinflammation, panniculitis, and dermatosis syndrome can manifest in early childhood with a variety of autoinflammatory sequelae, and patients has been described as responding to medical management (eg, with systemic steroids, IL1R antagonist, TNF inhibitor)Allergy/Immunology/Infectious27523608; 27559085; 35587511

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OTULIN gene.

  • not provided (137 variants)
  • Inborn genetic diseases (7 variants)
  • Infantile-onset periodic fever-panniculitis-dermatosis syndrome (6 variants)
  • not specified (4 variants)
  • Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection;Infantile-onset periodic fever-panniculitis-dermatosis syndrome (1 variants)
  • OTULIN-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OTULIN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
36
clinvar
4
clinvar
41
missense
57
clinvar
4
clinvar
61
nonsense
1
clinvar
1
start loss
1
clinvar
1
frameshift
2
clinvar
2
inframe indel
3
clinvar
1
clinvar
4
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
3
4
7
non coding
1
clinvar
19
clinvar
7
clinvar
27
Total 1 1 65 56 16

Variants in OTULIN

This is a list of pathogenic ClinVar variants found in the OTULIN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-14664712-G-A not specified Benign (Jan 24, 2024)2688224
5-14664823-C-T OTULIN-related disorder Likely benign (Sep 09, 2019)3040592
5-14664825-CA-C Uncertain significance (Nov 10, 2020)1462152
5-14664830-G-A Uncertain significance (May 20, 2022)1357898
5-14664832-C-T Uncertain significance (Oct 24, 2022)1898398
5-14664832-C-CG Uncertain significance (Aug 04, 2023)1421103
5-14664837-G-A OTULIN-related disorder Likely benign (Sep 29, 2023)1652466
5-14664840-T-A Likely benign (Jan 28, 2023)2793171
5-14664842-T-C not specified Uncertain significance (Dec 28, 2023)1378534
5-14664846-C-A Likely benign (Sep 10, 2023)1651398
5-14664847-C-T Infantile-onset periodic fever-panniculitis-dermatosis syndrome Pathogenic (Mar 06, 2020)1027708
5-14664852-C-T Likely benign (Oct 19, 2023)2876023
5-14664862-C-T Uncertain significance (Oct 12, 2021)1409582
5-14664866-G-A not specified Uncertain significance (Aug 09, 2022)1352481
5-14664879-C-T Likely benign (Oct 05, 2023)1926741
5-14664882-G-C Uncertain significance (Jan 14, 2022)2082527
5-14664886-C-G Uncertain significance (Jul 12, 2022)1479304
5-14664886-C-T Uncertain significance (Jun 11, 2022)1360340
5-14664886-CCGGCGCGGGAGGCGGCGGCCA-C Benign (Jan 31, 2024)1165553
5-14664888-G-T Likely benign (Oct 05, 2021)1608293
5-14664890-C-A Uncertain significance (Apr 11, 2023)2828525
5-14664890-C-T Uncertain significance (Jun 22, 2021)1363107
5-14664892-C-A Likely benign (Mar 04, 2023)1638016
5-14664895-GAGGCGGCGGCCACGGCGCGGGACGGCGGGA-G Uncertain significance (Jul 17, 2022)1925412
5-14664896-AGGC-A Uncertain significance (Jun 13, 2022)1909792

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OTULINprotein_codingprotein_codingENST00000284274 735048
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2200.778124787051247920.0000200
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.26911750.5200.000009712305
Missense in Polyphen2877.9590.35917886
Synonymous0.6466066.70.8990.00000381668
Loss of Function2.75415.80.2537.51e-7212

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.00005560.0000556
Finnish0.000.00
European (Non-Finnish)0.00002670.0000265
Middle Eastern0.00005560.0000556
South Asian0.000.00
Other0.0001660.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Deubiquitinase that specifically removes linear ('Met- 1'-linked) polyubiquitin chains to substrates and acts as a regulator of angiogenesis and innate immune response (PubMed:26997266, PubMed:23708998, PubMed:23746843, PubMed:23806334, PubMed:23827681, PubMed:27523608, PubMed:27559085, PubMed:24726323, PubMed:24726327, PubMed:28919039). Required during angiogenesis, craniofacial and neuronal development by regulating the canonical Wnt signaling together with the LUBAC complex (PubMed:23708998). Acts as a negative regulator of NF-kappa-B by regulating the activity of the LUBAC complex (PubMed:23746843, PubMed:23806334). OTULIN function is mainly restricted to homeostasis of the LUBAC complex: acts by removing 'Met-1'-linked autoubiquitination of the LUBAC complex, thereby preventing inactivation of the LUBAC complex (PubMed:26670046). Acts as a key negative regulator of inflammation by restricting spontaneous inflammation and maintaining immune homeostasis (PubMed:27523608). In myeloid cell, required to prevent unwarranted secretion of cytokines leading to inflammation and autoimmunity by restricting linear polyubiquitin formation (PubMed:27523608). Plays a role in innate immune response by restricting linear polyubiquitin formation on LUBAC complex in response to NOD2 stimulation, probably to limit NOD2- dependent proinflammatory signaling (PubMed:23806334). {ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:23746843, ECO:0000269|PubMed:23806334, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:24726323, ECO:0000269|PubMed:24726327, ECO:0000269|PubMed:26670046, ECO:0000269|PubMed:26997266, ECO:0000269|PubMed:27523608, ECO:0000269|PubMed:27559085, ECO:0000269|PubMed:28919039}.;
Disease
DISEASE: Autoinflammation, panniculitis, and dermatosis syndrome (AIPDS) [MIM:617099]: An autosomal recessive autoinflammatory disorder characterized by neonatal-onset of fever, neutrophilic dermatitis, panniculitis, painful joints, failure to thrive. Patients do not exhibit overt primary immunodeficiency. {ECO:0000269|PubMed:27523608, ECO:0000269|PubMed:27559085}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Signal Transduction;Post-translational protein modification;Metabolism of proteins;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;TNF signaling;Death Receptor Signalling;Regulation of TNFR1 signaling;Protein ubiquitination (Consensus)

Recessive Scores

pRec
0.103

Intolerance Scores

loftool
rvis_EVS
0.46
rvis_percentile_EVS
78.28

Haploinsufficiency Scores

pHI
0.106
hipred
Y
hipred_score
0.728
ghis
0.436

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Otulin
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; cellular phenotype;

Gene ontology

Biological process
sprouting angiogenesis;regulation of tumor necrosis factor-mediated signaling pathway;Wnt signaling pathway;negative regulation of NF-kappaB transcription factor activity;innate immune response;negative regulation of inflammatory response;regulation of canonical Wnt signaling pathway;nucleotide-binding oligomerization domain containing 2 signaling pathway;protein linear deubiquitination
Cellular component
cytoplasm;cytosol;LUBAC complex
Molecular function
thiol-dependent ubiquitin-specific protease activity;protein binding;cysteine-type peptidase activity